ATE133682T1 - Verfahren zur herstellung von 2-amino-9-(2,3,5- tri-0-benzyl-beta-d-arabinofuranosyl)adenin und neue zwischenprodukte - Google Patents
Verfahren zur herstellung von 2-amino-9-(2,3,5- tri-0-benzyl-beta-d-arabinofuranosyl)adenin und neue zwischenprodukteInfo
- Publication number
- ATE133682T1 ATE133682T1 AT91901479T AT91901479T ATE133682T1 AT E133682 T1 ATE133682 T1 AT E133682T1 AT 91901479 T AT91901479 T AT 91901479T AT 91901479 T AT91901479 T AT 91901479T AT E133682 T1 ATE133682 T1 AT E133682T1
- Authority
- AT
- Austria
- Prior art keywords
- beta
- arabinofuranosyl
- adenine
- tri
- benzyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/445,446 US5110919A (en) | 1989-12-04 | 1989-12-04 | Process for the preparation of 2-amino-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine and novel intermediates |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE133682T1 true ATE133682T1 (de) | 1996-02-15 |
Family
ID=23768933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91901479T ATE133682T1 (de) | 1989-12-04 | 1990-11-30 | Verfahren zur herstellung von 2-amino-9-(2,3,5- tri-0-benzyl-beta-d-arabinofuranosyl)adenin und neue zwischenprodukte |
Country Status (9)
Country | Link |
---|---|
US (2) | US5110919A (de) |
EP (1) | EP0456817B1 (de) |
JP (2) | JPH07634B2 (de) |
AT (1) | ATE133682T1 (de) |
DE (2) | DE456817T1 (de) |
DK (1) | DK0456817T3 (de) |
ES (1) | ES2038094T3 (de) |
GR (2) | GR920300026T1 (de) |
WO (1) | WO1991008215A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5110919A (en) * | 1989-12-04 | 1992-05-05 | Ash Stevens, Inc. | Process for the preparation of 2-amino-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine and novel intermediates |
CA2091732C (en) * | 1992-07-08 | 1998-07-21 | Anica Markovac | A process for the preparation of 2-fluoro-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine |
US5602246A (en) * | 1992-11-25 | 1997-02-11 | Schering Aktiengesellschaft | Process for the preparation of fludarabine or fludarabine phosphate from guanosine |
HU226997B1 (en) * | 1997-12-11 | 2010-04-28 | Alcafleu Man Gmbh & Co Kg | Method for producing lithium, sodium, potassium, calcium and magnesium salts of fludarabin phosphate purification method for producing fludarabin phosphate and fludarabin phosphate which is at least 99,5% pure |
PT1261350E (pt) * | 2000-02-18 | 2006-11-30 | Southern Res Inst | Processos para síntese de 2-cloro-9-(2-desoxi-2-fluoro-b-d-arabinofuranosil)-9h-purin-6-amina |
DE10164510A1 (de) * | 2001-12-20 | 2003-07-10 | Schering Ag | Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes |
US7491725B2 (en) | 2004-02-06 | 2009-02-17 | Bristol-Myers Squibb Company | Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
EP3342778B1 (de) * | 2015-08-28 | 2022-01-12 | Zhejiang Hisun Pharmaceutical Co., Ltd. | Kristallform von fludarabin-phosphat, herstellungsverfahren dafür und anwendung davon |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3008969A (en) * | 1958-05-21 | 1961-11-14 | American Cyanamid Co | 4-substituted-7-carboalkoxyamino-coumarins |
USRE29835E (en) * | 1971-06-01 | 1978-11-14 | Icn Pharmaceuticals | 1,2,4-Triazole nucleosides |
US4188378A (en) * | 1978-01-04 | 1980-02-12 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Anticancer and antiviral activity of 9-β-D-arabinofuranosyl-2-fluoroadenine |
US5110919A (en) * | 1989-12-04 | 1992-05-05 | Ash Stevens, Inc. | Process for the preparation of 2-amino-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine and novel intermediates |
-
1989
- 1989-12-04 US US07/445,446 patent/US5110919A/en not_active Expired - Lifetime
-
1990
- 1990-11-30 DE DE199191901479T patent/DE456817T1/de active Pending
- 1990-11-30 ES ES91901479T patent/ES2038094T3/es not_active Expired - Lifetime
- 1990-11-30 EP EP91901479A patent/EP0456817B1/de not_active Expired - Lifetime
- 1990-11-30 WO PCT/US1990/007004 patent/WO1991008215A1/en active IP Right Grant
- 1990-11-30 AT AT91901479T patent/ATE133682T1/de not_active IP Right Cessation
- 1990-11-30 DE DE69025176T patent/DE69025176T2/de not_active Expired - Fee Related
- 1990-11-30 JP JP3501945A patent/JPH07634B2/ja not_active Expired - Fee Related
- 1990-11-30 DK DK91901479.5T patent/DK0456817T3/da active
-
1992
- 1992-04-30 US US07/876,412 patent/US5296589A/en not_active Expired - Fee Related
- 1992-08-26 GR GR92300026T patent/GR920300026T1/el unknown
-
1994
- 1994-06-30 JP JP6149934A patent/JPH07108912B2/ja not_active Expired - Fee Related
-
1996
- 1996-04-16 GR GR960401037T patent/GR3019656T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0456817A4 (en) | 1992-04-22 |
JPH04504268A (ja) | 1992-07-30 |
EP0456817A1 (de) | 1991-11-21 |
DE69025176T2 (de) | 1996-05-30 |
JPH07634B2 (ja) | 1995-01-11 |
DK0456817T3 (da) | 1996-04-29 |
GR920300026T1 (en) | 1992-08-26 |
US5110919A (en) | 1992-05-05 |
GR3019656T3 (en) | 1996-07-31 |
ES2038094T3 (es) | 1996-06-01 |
DE456817T1 (de) | 1992-04-09 |
ES2038094T1 (es) | 1993-07-16 |
US5296589A (en) | 1994-03-22 |
WO1991008215A1 (en) | 1991-06-13 |
JPH07138280A (ja) | 1995-05-30 |
EP0456817B1 (de) | 1996-01-31 |
JPH07108912B2 (ja) | 1995-11-22 |
DE69025176D1 (de) | 1996-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE121088T1 (de) | Verfahren zur herstellung von imidazo(4,5- c>chinolin-4-aminen. | |
DE3876732D1 (de) | Verfahren zur herstellung eines kohlenstoff-kohlenstoff-verbundkoerpers von hoher festigkeit. | |
ATE226949T1 (de) | Verfahren zur herstellung von tolterodin | |
ATE82274T1 (de) | Morphologisch homogene formen von famotidin und verfahren zu deren herstellung. | |
DE69434532D1 (de) | Verfahren zur Herstellung eines Produktes mit hohem Trehalosegehalt | |
ATE132904T1 (de) | Verfahren zur herstellung von trehalulose und isomaltulose | |
DE68916086D1 (de) | Verfahren zur Herstellung von Kohlenstoff/Kohlenstoff-Verbundstoffen. | |
DE3883408D1 (de) | Verfahren zur Herstellung von Avermectinen und die verwendeten Kulturen. | |
ATE194142T1 (de) | Verfahren zur herstellung von nukleotiden | |
DE3774784D1 (de) | Verfahren und anordnung zur herstellung eines reaktionsproduktes. | |
DE68909627D1 (de) | Verfahren zur Herstellung von Aktivkohle. | |
DE69025176D1 (de) | Verfahren zur herstellung von 2-amino-9-(2,3,5-tri-0-benzyl-beta-d-arabinofuranosyl)adenin und neue zwischenprodukte | |
DE3882453D1 (de) | Verfahren zur herstellung von ibuprofen. | |
ATE204283T1 (de) | Verfahren zur herstellung von 2,2- difluorketensilylacetalen und alpha,alpha-difluor-beta -silyloxy-1,3-dioxolan-4-propansäureestern | |
ATE101124T1 (de) | Verfahren zur herstellung von aminocyanacetamid. | |
ATE99662T1 (de) | Verfahren zur herstellung von 1,1-dichlor-1fluorethan. | |
DE69106360D1 (de) | Verfahren zur herstellung von 1,1-dichlor-1-fluorethan. | |
DE68904137D1 (de) | Verfahren zur herstellung von 1,1,-dichlor-1-fluoroethan. | |
DE59005334D1 (de) | Verfahren zur Herstellung von reinem Guanin. | |
DE68928634D1 (de) | Verfahren zur Herstellung von aktivierten Killer-Monozyten und Verfahren zur Überprüfung ihrer tumoriziden Aktivität | |
AT389065B (de) | Verfahren zur herstellung eines brenners, insbesondere gasbrenners sowie nach diesem verfahren hergestellter brenner | |
ATE150438T1 (de) | Verfahren zur herstellung von 1,1,1,2- tetrafluorethan | |
ATE100148T1 (de) | Verfahren zur herstellung von hochgradig ungesaettigten fettsaeuren. | |
DE3765000D1 (de) | Verfahren zur herstellung von gamma-butyrobetain. | |
DE69218865D1 (de) | Verfahren und Vorrichtung zur Herstellung von Glasgegenständen nach dem Pressblasverfahren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |